
Advertise on podcast: Addiction Medicine Made Easy | Fighting back against addiction
Rating
4.9from
This podcast has
205 episodes
Language
EnglishPublisher
Casey Grover, MD, FACEP, FASAMExplicit
No
Date created
2021/05/04
Latest episode
2026/11/09
Average duration
32 min.
Release period
8 days
Description
Addiction is killing us. Over 100,000 Americans died of drug overdose in the last year, and over 100,000 Americans died from alcohol use in the last year. We need to include addiction medicine as a part of everyone's practice! We take topics in addiction medicine and break them down into digestible nuggets and clinical pearls that you can use at the bedside. We are trying to create an army of health care providers all over the world who want to fight back against addiction - and we hope you will join us.*This podcast was previously the Addiction in Emergency Medicine and Acute Care podcast*
Unlock Addiction Medicine Made Easy | Fighting back against addiction podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Addiction Medicine Made Easy | Fighting back against addiction podcast
The Intersection Between Chronic Pain and Addiction
2026/11/09
Chronic pain and addiction are often treated like separate problems, but in real life they are tangled together every day, sometimes with life-or-death stakes. I’m Dr Casey Grover, and I’m joined by family physician and addiction expert Dr Matthew Parker to talk through what actually happens when long-term opioid therapy, stigma, and shifting regulations collide with genuine suffering. Along the way we name a painful reality: “opioid orphans”, patients with legitimate chronic pain who get cut off from care and may feel cornered into risky choices.
We break down opiate-induced hyperalgesia in simple terms and why escalating opioid doses can paradoxically increase pain over time. We also map the spectrum between a “pure pain patient” and “pure opioid use disorder”, then focus on the wide middle where most people live. That’s where thoughtful co-management can matter most, including safer medication options like buprenorphine or methadone, harm reduction tools like naloxone, and non-opioid pain strategies that support function instead of just chasing a number on a pain scale.
The conversation keeps coming back to one question that changes the tone of care: What happened to you? We talk trauma-informed care, PTSD in veterans and first responders, and why education and trust often do more than confrontation. We also touch on under-discussed contributors to suffering such as opioid-related hormone suppression, low testosterone, and the vicious cycle of pain, inactivity, and deconditioning. Dr Parker shares his work with RehabNet.com, a medically reviewed resource to help people find addiction treatment options across the US.
If this resonates, subscribe for more practical addiction medicine conversations, share this with someone navigating pain or recovery, and leave a review so more people can find the show.
Link to RehabNet.Com: https://rehabnet.com/
To contact Dr. Grover: [email protected]
How Families Can Stop Enabling And Start Recovery
2026/11/02
Addiction doesn’t just hijack one person, it reorganises the whole family around fear, guilt, and constant crisis. We sit down with interventionist Mike Loverde, founder of Family First Intervention, to talk about what actually happens inside families when substance use disorder takes over and why “waiting until they want help” can quietly become the plan that keeps everyone stuck.
We dig into family systems theory in plain language and name the roles that show up again and again: the enabler who cannot hold the line, the hero who tries to be perfect and can sabotage the process, the martyr who fears being left behind if recovery happens, plus the scapegoat and the lost child. Mike explains how these roles aren’t character flaws, they’re coping strategies that become barriers to treatment, and why changing the family environment is a major predictor of outcomes in addiction recovery.
We also walk through what a professional, structured intervention can look like when it’s done with compassion: tight decision-making, clear boundaries, letters that avoid attacks, and practical planning that pre-handles every “what about…” excuse (work, pets, travel, money). Then we talk aftercare, fact-checking manipulation, preventing AMA discharges, and the difference between enabling and helping, all with real examples families will recognise.
If you found this useful, subscribe, share it with someone supporting a loved one, and leave a rating or review so more families can find the help they need.
To learn more about Mike's work: https://family-intervention.com/
To buy Mike's book: https://a.co/d/0aXdYP7N
To contact Dr. Grover: [email protected]
Can TMS And Ketamine Be Used to Treat Addiction??
2026/10/26
Cravings, relapse, and “bad choices” make a lot more sense when you view addiction as a brain network problem. We sit down with Dr Philip Yam, a psychiatrist at Serenity Mental Health Centers and former active duty Navy psychiatrist, to get a practical, plain-English look at two treatments that keep coming up in mental health and addiction care: transcranial magnetic stimulation (TMS) and ketamine therapy.
We start with TMS: what it is, how it uses electromagnetic pulses to stimulate specific brain regions, and why targeting the prefrontal cortex can improve regulation over limbic “fight or flight” circuits tied to depression, PTSD, anxiety, ADHD, and substance use disorder. Then we zoom in on addiction-focused protocols that target the insula, a key hub for cravings and decision making, and talk about what a real TMS course looks like, including standard multi-week schedules and accelerated options.
Next we pivot to ketamine infusion for treatment-resistant depression and suicidality, including the glutamate and neuroplasticity story, why low-dose ketamine is not the same as anesthetic dosing, and how dosing is individualized. We also tackle the hard part: ketamine is a drug of abuse. We talk ketamine bladder, why clinics keep it controlled, and how we think about risk when someone has a polysubstance history. We close with how and when combining ketamine with TMS can help, and a decision framework for choosing what to try first.
If this conversation helps you think differently about recovery and brain-based treatment, subscribe, share it with a colleague or friend, and leave a review so more people can find the show.
To contact Dr. Grover: [email protected]
No Filter — The Truth About Vaping and EVALI
2026/10/19
Vaping looks sleek, smells sweet, and gets marketed like a harmless upgrade from cigarettes, but the science and the bedside reality are messier than most people realize. We walk through why e-cigarettes became popular in the first place, starting with a blunt truth: combustible tobacco is one of the most toxic things humans routinely use, and nicotine dependence is powerful. That “need for a safer cigarette” helped launch a global industry that now delivers nicotine in faster, stronger, more appealing ways than early e-cigarettes ever could.
From there, we get practical and specific about what a vape is and what it does. We break down the basic hardware (battery, heating coil, liquid tank) and how the market evolved from cigarette lookalikes to pens, mods, pods, and today’s disposable devices built around flavors and convenience. Then we dig into the e-liquid itself: nicotine plus solvents like propylene glycol and vegetable glycerin, along with flavoring agents. When those liquids are heated into an aerosol, chemical reactions create new byproducts, and users may also inhale metals shed from the coil. If you’ve ever wondered what you’re actually pulling into your lungs with each puff, this section will sharpen your questions fast.
The core medical focus is EVALI, or e-cigarette and vaping acute lung injury. We explain the symptoms (cough, shortness of breath, low oxygen, fluid in the lungs), why it can be mistaken for asthma, pneumonia, bronchitis, or even COVID, and why clinicians often diagnose it by ruling out other causes. We also cover why THC cartridges and refillable products raised risk in the 2019 outbreak, including what researchers learned about vitamin E acetate and toxic exposure when it’s heated. We close with what prognosis can look like, from improvement after stopping to permanent lung damage.
If this helped you think more clearly about vaping risks, share it with someone who vapes, then subscribe and leave a rating or review so more people can find the show.
To contact Dr. Grover: [email protected]
Lived Experience: The Line Between Personal and Professional
2026/10/12
“Lived experience” is one of the most powerful tools in addiction medicine, and one of the easiest ways to accidentally get it wrong. When we tell a patient “I’ve been there,” we can create instant trust and reduce shame. We can also, without meaning to, steer care toward our own story, our own recovery path, or our own triggers.
I sit down with Randall Law, a psychiatry physician assistant in Idaho who works in residential and outpatient addiction treatment with a heavy focus on dual diagnosis. Randall shares his own mental health journey, including an episode of manic psychosis that spiraled into a life-threatening crisis in Hawaii during COVID, and how he rebuilt his life and returned to clinical practice. We talk openly about anxiety, stability, and the daily work of staying well while caring for patients in some of their hardest moments.
From there we get practical: when should a clinician share personal history, and when should we keep it private? Randall lays out simple decision rules for self-disclosure, and I share ways I flag the difference between anecdote and evidence so patients know what they are hearing. We also discuss validating psychosis without reinforcing delusions, why motivational interviewing and bedside manner are not “extras” in psychiatry, and how lived experience can support both patient recovery and provider resilience.
If this conversation helps you think differently about boundaries, bias, peer support, or compassionate communication, please subscribe, share the episode with a colleague, and leave a review so more people can find the show.
To contact Dr. Grover: [email protected]
Is Pure, High Dose, CBD Ready for the Prescription Pad?
2026/10/05
Most CBD products leave clinicians and patients guessing: unclear labels, inconsistent dosing, and the lingering worry of THC exposure. I’m Dr. Casey Grover, and as an addiction medicine physician I came into this conversation skeptical because I treat cannabis use disorder and I’ve seen how “cannabis-adjacent” products can go sideways in real life. Then I sat down with Pulak Sharma, founder and CEO of Kazmira Therapeutics, and Dr. Marwaha, an internal medicine physician, to dig into what changes when CBD is treated like a true medical therapy rather than a supplement.
We talk about what “prescription-grade” CBD actually means, including 503A compounding standards, a vertically integrated process, and why THC-free purity matters for prescribing, drug testing concerns, and patient safety. Dr. Marwaha shares how he’s using high-dose pure cannabidiol as an adjunct for generalized anxiety and chronic pain, especially in older adults who can’t tolerate NSAIDs or who become confused or sedated on typical options like gabapentin or muscle relaxers. We also get practical about what to monitor: medication interactions, liver function tests, and the real-world side effects he sees most often, like drowsiness and nausea.
We don’t dodge the evidence gaps. Instead, we discuss how structured outcomes tracking (think GAD-7 and PHQ-9) could build credible data around reduced reliance on benzodiazepines, opioids, and other higher-risk meds, and how telemedicine may expand access while keeping protocols consistent. We even explore what’s next, from nanoemulsion tech for faster onset to endometriosis pain and veterinary use where THC can be toxic to pets.
Subscribe, share this with a skeptical friend, and leave a review so more people can find the show.
To contact Dr. Grover: [email protected]
To learn more about Kazmira's work: https://www.kazmiratx.com/
We Use More Than One Medication To Treat Diabetes and Hypertension - Let's Do The Same for Alcohol Use Disorder!
2026/09/28
One-med-at-a-time sounds tidy on paper, but alcohol use disorder rarely behaves like a tidy problem. Dr. Reb Close and I sat down to discuss treating alcohol use disorder, and we’ve learned that many patients do better when we treat AUD the way we treat other chronic conditions: with a multimodal plan that targets more than one pathway and stays anchored to the person’s real reason for drinking.
We walk through how we think about combination medication strategies for alcohol cravings, including naltrexone, acamprosate, gabapentin, baclofen, and topiramate. You’ll hear the practical “why” behind pairing meds, how we set expectations for naltrexone response, and how targeted dosing can give patients more control during high-risk moments. We also talk about monthly extended-release naltrexone (Vivitrol) and how we approach add-on oral dosing without overdoing it.
Just as important, we keep coming back to the central clinical question: what does alcohol do for you? If drinking is driven by anxiety, insomnia, or trauma, the best AUD treatment may start with sleep, PTSD symptoms, nightmares, or triggers rather than another anti-craving pill. We close by zooming out to what best practice really looks like: therapy or groups, good sleep, nutrition, exercise, treatment of co-occurring mental health conditions, and more than one medication when it fits.
Subscribe for more practical addiction medicine, share this with a clinician or friend who cares about recovery, and please leave a review so more people can find the show.
To contact Dr. Grover: ammadeeasy@fastmailcom
We Didn't Start the Fire — But We're Burning Out
2026/09/21
Burnout doesn’t always announce itself with a crash. Sometimes it creeps in while you’re still achieving, still leading, still doing “all the right things” until you notice you’re dreading shifts, snapping at people you love, or feeling numb with patients. That’s where our conversation goes, with James Maskalyk, an emergency physician in downtown Toronto, the first wellness director in his division, and someone who has helped bring emergency medicine training and wellness thinking to Ethiopia.
We get honest about what high-stress healthcare work does to the body and mind: shift work, chronic cortisol, trauma exposure, PTSD, and the subtle slide into depersonalisation. We also talk about the system problem, not just the individual problem, when pay and performance are tied to throughput instead of the quality of care and the humanity of the clinician. Along the way, we share the moments that changed how we see “wellness,” including the realization that medicine is an act of empathy and you can’t pour from an empty cup.
Then we move into practical, real-world tools: taking meaningful time away (including month-long sabbaticals), creating space inside the ER for small moments of connection, building peer support, and doing debriefs that help teams process what they just lived through. We also discuss journaling, creative work, and therapy as ways to build vocabulary for what you’re carrying so you can make changes earlier, not years later. If this resonates, subscribe, share it with a colleague, and leave a review so more healthcare workers can find it.
To contact Dr. Grover: [email protected]
Dr. Maskalyk's substack: https://jamesmaskalyk.substack.com/
Does Letting Your Teen Drink at Home Prevent Drug and Alcohol Problems?
2026/09/14
The idea sounds caring and practical: if my teen is going to drink anyway, I’d rather it happen at home where I can supervise it. I’m Dr. Casey Grover, and after years in emergency medicine and now addiction medicine, I keep hearing this “safe at home” approach framed as a way to teach responsible drinking and prevent future addiction. The problem is that good intentions are not the same as good outcomes, and the research on parental permission is far less comforting than most families expect.
We walk through six studies that directly test whether allowing underage alcohol use (and the same logic often applied to cannabis) provides a protective effect. Across surveys and longitudinal data, the pattern points in one direction: permissive attitudes and permission to drink at home are associated with more frequent use, higher quantities, and more alcohol-related harms later on. We dig into findings on teens drinking without parental knowledge, the risk of alcohol being taken from the home, and how early “sips” or “tastes” can predict heavier drinking in late adolescence even after controlling for other factors.
We also get practical about what helps. The evidence supports clear boundaries, consistent discipline around drinking, and direct communication about risks. One of the most sobering insights is how often parents underestimate how much teens drink, especially when parents believe that controlled access at meals is protective. If you’re a parent, caregiver, clinician, or student, you’ll leave with concrete takeaways you can use in real conversations at home and in the clinic.
If this was useful, subscribe, share it with someone raising a teen, and please leave a review so more people can find Addiction Medicine Made Easy. Huge thanks to Central Coast Overdose Prevention for supporting the show, and remember: treating addiction saves lives.
To contact Dr. Grover: [email protected]
Skip The Strip: Talking Direct to Inject for OUD With Dr. Reb Close
2026/09/07
Getting someone from fentanyl to buprenorphine can be one of the hardest transitions in addiction medicine, and not because people “don’t want it.” The pharmacology is unforgiving: start too soon and precipitated withdrawal can hit fast, loud, and memorable enough that patients never want to try bupe again. We sit down with Dr. Reb Close to talk through a newer approach that’s gaining traction, Direct To Inject (DTI), and what it looks like when you actually do it in the real world.
We explain why fentanyl’s long tail changes everything, then map the options we offer patients: macrodosing, microdosing with a cross taper, microdosing without a cross taper, and DTI. You’ll hear how DTI uses a weekly long-acting injectable buprenorphine dose that comes on over about 24 hours, effectively creating a built-in “microdose ramp” while the patient navigates that first day. We also get specific about comfort meds, safety counselling, and how we handle the common moment where someone feels terrible but hasn’t taken any of the meds meant to help.
From street-based care to clinic workflows, we share what withdrawal severity looks like across patients, when DTI is not a good option, how we think about methadone switches, and why we often push toward high-dose monthly injectable buprenorphine for a longer protective tail. If you care about practical fentanyl-era buprenorphine induction, retention, and overdose prevention, this one is for you. Subscribe, share with a colleague, and leave a review so more people can find the show.
To contact Dr. Grover: [email protected]
Sober Living Explained
2026/08/31
Walking out of treatment can feel like being dropped right back into the fire: the bills are higher, relationships are still strained, triggers are everywhere, and the old “solution” of numbing out is suddenly right there again. We wanted a clearer answer to a common question from patients, families, and clinicians: what is sober living, and how does it actually help?
I sit down with Gerald Lott, host of the Seeds of Recovery podcast, author, and executive director of Sauk Valley Voices of Recovery in Illinois. Gerald breaks down sober living as real-life practice with guardrails: peer-led structure, house rules, curfews, chores, and meeting requirements that taper over time. We also talk about the differences between a recovery home (treatment without walls), sober living, Oxford House style models, and why it’s essential to vet programmes carefully because predatory sober homes do exist.
A huge thread running through our conversation is connection. Gerald explains why recovery built only on shared trauma can fade as you stabilise, and how “tribe” and affinity groups like sports, music, fishing, running, art, and service can keep connection growing in long-term recovery. We get practical about life skills too: budgeting, work routines, repairing relationships, and how recovery coaching turns big goals into weekly steps.
If you care about addiction recovery, relapse prevention, sober living programmes, or how peer recovery specialists support lasting change, this one is for you. Subscribe, share with someone who needs a next step after treatment, and leave a review so more people can find the show.
* Note * - there is some adult language in this episode
To contact Dr. Grover: [email protected]
Ozempic Goes to Rehab: GLP-1s for Addiction
2026/08/24
GLP-1 medications are everywhere right now, and not just because people are losing weight. We’re starting to see something far more interesting for addiction medicine: semaglutide may reduce alcohol cravings and heavy drinking, and early data hints it could influence other compulsive behaviors too. I recorded this talk after giving it as a lecture to my colleagues, and it’s one I’ve wanted to share for a long time because the science is moving fast and the clinical questions are piling up.
We walk through what GLP-1 drugs actually are, how gut hormones like GLP-1 and GIP shape appetite, digestion, and glycaemic control, and why side effects like nausea and bloating are so common. I also clear up the most confusing practical point patients run into: Ozempic versus Wegovy and Mounjaro versus Zepbound are often the same molecules labelled for different indications, and insurance coverage usually follows those rules.
Then we get into the addiction evidence. I review three recent randomized controlled trials from 2025 to 2026 studying semaglutide for alcohol use disorder, including injectable and oral versions. The results aren’t magic, but they’re meaningful: fewer drinks on drinking days, fewer heavy drinking days, and lower craving scores compared with placebo, plus secondary findings that raise new research questions about nicotine and cannabis. Finally, I share two de-identified patient cases that show why GLP-1s can be a game-changer for some people and only a small nudge for others, especially when depression, grief, anxiety, or PTSD is the true engine behind drinking.
If this helped you think differently about recovery tools, subscribe, share the show with a colleague or friend, and leave a review so more people can find it.
To contact Dr. Grover: [email protected]
The Most Effective Stress Relief You Should Never Use
2026/08/17
In this episode, Dr. Grover sits down with his daughter to discuss some of the more subtle aspects of quitting smoking. If you're wondering why it was his daughter, well - she was home when the recording was happening and it just felt right.
Smoking isn’t just nicotine, it’s a whole stress ritual hiding in plain sight. We’ve both seen it: someone can do the brutal work of getting sober from alcohol or stopping opioids, yet cigarettes or vaping stay glued to their day. So we slow down and ask a more honest question: if nicotine gum, lozenges, and patches can cover withdrawal, why does quitting smoking still take so many serious attempts?
We break nicotine dependence down in plain language, including why nicotine can feel like both an upper and a downer, what nicotine withdrawal looks like, and how nicotine replacement therapy fits into a real smoking cessation plan. Then we get into the part people rarely name: the behavioral addiction. The hand-to-mouth routine becomes automatic, and the body starts craving the motion and timing just as much as the chemical.
From there we lay out three hidden reinforcers that make smoking and vaping feel calming: paced breathing that works like an anxiety exercise, the built-in permission of a smoke break, and the walk away from people that restrictions and stigma often force. We also connect this to early recovery and post-acute withdrawal syndrome (PAWS), when the brain is already dysregulated and anxiety can run high at work. If quitting removes your breathing, breaks, and escape all at once, of course cravings surge.
Listen for practical ways to replace the ritual without keeping the smoke: schedule breaks on purpose, keep the walk, practice box breathing, and use evidence-based supports when needed. If this helps you or someone you love, subscribe, share the episode, and leave a review so more people can find it.
To contact Dr. Grover: [email protected]
What Do You Do With the Patient Using Everything? (Rebroadcast)
2026/08/11
Polysubstance use is where addiction medicine stops being a single-problem visit and becomes real clinical triage. When someone is using alcohol, fentanyl, methamphetamine, benzodiazepines, cannabis, nicotine, and whatever else is in the supply, the hardest part is not naming the diagnosis, it’s deciding what to treat first and how to do it safely. We brought back a remastered conversation with Monterey addiction physician Dr Lee Goldman to walk through the thinking that keeps patients alive and keeps clinicians from getting lost in overlapping symptoms.
We talk through how we build the “priority list” using the patient’s own reason for coming in, the dysfunction the substance is causing, and objective tools like urine toxicology while remembering that some sedatives may not show up. Dr Goldman explains why alcohol withdrawal risk often rises to the top, how fentanyl changes buprenorphine inductions through precipitated withdrawal, and why unknown medications like Soma or unmentioned methadone can derail an otherwise solid plan. You’ll hear why many clinicians stabilise one withdrawal syndrome at a time, and what harm reduction looks like when “stop everything today” is not realistic.
We also get honest about the messy questions: what does sobriety mean when someone says they’re “sober” but still using cannabis, benzodiazepines, or kratom? How do residential, partial hospital, IOP, and outpatient settings change what we can require and what we can monitor? Why is nicotine so normalised in recovery spaces, and when is the right time to address it? Dr Goldman makes a strong case that benzodiazepines may be the toughest substance to treat, especially with anxiety and PTSD in the background, and we close with what’s changing in drug mixes and where behavioural addictions may be heading next.
Subscribe to Addiction Medicine Made Easy, share this with a colleague, and leave a review so more people can find the show.
To contact Dr. Grover: [email protected]
Ibogaine: A Miracle Cure for Addiction?
2026/08/03
Ibogaine is being talked about like a moonshot for addiction treatment and mental health. But when a substance is powerful enough to reshape cravings, mood, and perception, it is also powerful enough to hurt people when the science and safety systems lag behind.
This is Dr. Casey Grover and Addiction Medicine Made Easy, and this is a recording of a lecture that digs into what ibogaine is, why it’s back in US headlines, and how real people are already accessing ibogaine clinics just across the border. We walk through a cautionary story of a patient told she was “cured,” only to relapse immediately, and use that to underline a central point: no single intervention replaces a durable recovery plan.
You’ll hear a clear, clinician-friendly breakdown of ibogaine’s proposed mechanisms across multiple brain pathways (dopamine, serotonin, NMDA, opioid receptors, and more), what the ibogaine experience is typically like across its phases, and why this psychedelic therapy is not “benign.” We spend serious time on ibogaine safety, including QT prolongation, torsades de pointes, ventricular tachycardia, and how underlying heart conditions or mixing substances can turn treatment into tragedy.
Finally, we get geeky about evidence. We explain the different types of research studies, why “the plural of anecdote is not data,” and what the best available studies actually show for cravings, opioid withdrawal, PTSD, depression, and cocaine use. If you’re considering ibogaine for opioid addiction, ibogaine detox, or ibogaine for PTSD, we close with practical guidance on what we recommend today: medication assisted treatment like buprenorphine, methadone, or naltrexone, plus groups and individual therapy, with any experimental route followed by standard recovery work.
Subscribe, share this with someone who’s curious about ibogaine, and leave a review so more people can find careful, compassionate addiction medicine.
To contact Dr. Grover: [email protected]
Podcast reviews
Read Addiction Medicine Made Easy | Fighting back against addiction podcast reviews
Colette317 2026/10/25
This was the info I’ve been needing!!
Very informative and relatable. Will be listening to more of your podcasts. Recovering addict that just switched from the strip to Brixalti. Thank you...
Randall Law 2026/10/13
Relatable and Informative Content from a Skilled Provider
Dr. Grover is a skilled provider in both emergency medicine and now addiction medicine. His breadth of knowledge and expertise is impressive and a lit...
PS11248 2026/10/06
Great podcast!
Fascinating to learn about cutting edge, new therapeutic options in the important addiction medicine space
Missnaznaz 2026/07/19
Amazing podcast!
I absolutely love Addiction Medicine Made Easy! As someone who practices in addiction medicine, I truly appreciate how this resource takes topics that...
AnniHQ 2026/07/14
This podcast will save lives!
In this podcast Dr. Glover brings enormous compassion, first-hand knowledge, and vast experience in addiction treatment. He is clearly devoted to the...
Louise D Barnett 2026/06/26
Real conversations, real education, and no fluff.
This podcast is doing the work. Real conversations, real education, and no fluff. Addiction is messy, complex, and deeply human, and this show doesn’t...
Guerope 2026/06/26
The title says it all
Coverage of Kratom was the best explanation for its effects and treatment. Brings a confusing substance to an understandable level. Well done! Also li...
LemonsAndTennis 2026/06/16
Excellent listen
Thank you Dr Grover for making this podcast. I love hearing your perspective and the knowledge drops helped me pass addiction med boards.
Go Humans! 2026/05/25
A Recovery Warrior
I’m a huge fan! Dr. Casey Grover’s Addiction Medicine Made Easy is, in my opinion, one of the most important and intellectually fearless addiction and...
April C-NP 2026/05/21
A must listen podcast!
Consistently informative content presented in an easily digestible form.
Dr Grover is not only knowledgeable but overflows with compassion for educa...
Podcast sponsorship advertising
Start advertising on Addiction Medicine Made Easy | Fighting back against addiction relevant audience podcasts
You may also like to advertise on these Podcasts

4.443671371
Something You Should Know
Mike Carruthers | OmniCast Media

4.7906254
Everything is Fine
Jennifer Romolini and Kim France

4.610916582
Serialously with Annie Elise
Annie Elise & Audioboom Studios

4.41171483
The Outlier Health Podcast
Matt Frazier, Matt Tullman, Isabelle Caputo, and Doug Hay

4.616224366
Giggly Squad
Hannah Berner & Paige DeSorbo

4.8219787
Imperfect Action
Steph Taylor

4.727637592
This Past Weekend w/ Theo Von
Theo Von

4.713055379
The Tim Dillon Show
The Tim Dillon Show

4.116097472
The Tucker Carlson Show
Tucker Carlson Network

4.828116459
Huberman Lab
Scicomm Media